Valiant Laboratories Ltd.

Financial

	Valiant Laboratories	Medicamen Biotech	Fredun Pharma
Operational Metrics
Financials
5 yr Average ROE	22.49 %	8.49 %	8.53 %
5yr average Equity Multiplier	2.04	1.47	3.02
5yr Average Asset Turnover Ratio	1.23	0.58	1.01
5yr Avg Net Profit Margin	6.1 %	10.0 %	2.89 %
Price to Book	2.07	2.26	3.49
P/E	0.0	50.58	21.09
5yr Avg Cash Conversion Cycle	77.97 Days	13.14 Days	137.13 Days
Inventory Days	19.05 Days	66.66 Days	140.46 Days
Days Receivable	134.62 Days	122.66 Days	52.11 Days
Days Payable	71.52 Days	257.34 Days	131.93 Days
5yr Average Interest Coverage Ratio	238.24	10.36	2.31
5yr Avg ROCE	18.33 %	12.12 %	16.75 %
5yr Avg Operating Profit Margin	6.8 %	16.84 %	8.32 %
5 yr average Debt to Equity	0.59	0.14	0.86
5yr CAGR Net Profit	-58.96 %	-6.51 %	52.4 %
5yr Average Return on Assets	9.61 %	5.75 %	3.05 %
Shareholdings
Promoter Holding	74.94 %	40.46 %	48.93 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-3.14 %	-2.11 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Valiant Laboratories	Medicamen Biotech	Fredun Pharma
Product Wise Break-Up	Product Wise Break-Up Paracetamol 100.0 Pharmaceuticals Formulations 0 0	Product Wise Break-Up Paracetamol 0 0 Pharmaceuticals Formulations 100.0	Product Wise Break-Up Paracetamol 0 Pharmaceutical 100.0 Pharmaceuticals Formulations 0
Location Wise Break-Up	Location Wise Break-Up India 99.49 Rest of the World 0 Others 0.51	Location Wise Break-Up India 20.0 Rest of the World 0 Others 80.0	Location Wise Break-Up India 77.22 Rest of the World 22.32 Others 0.46
Asset Break-Up - Geography Wise	Asset Break-Up - Geography Wise India 100.0	-	-